Search

Your search keyword '"Cook, Rebecca"' showing total 1,466 results

Search Constraints

Start Over You searched for: Author "Cook, Rebecca" Remove constraint Author: "Cook, Rebecca"
1,466 results on '"Cook, Rebecca"'

Search Results

2. Structural optimization of siRNA conjugates for albumin binding achieves effective MCL1-directed cancer therapy

7. Diagnosis and Acute Management of COVID-19 and Multisystem Inflammatory Syndrome in Children

11. Polymeric Micellar Nanoparticles Enable Image-guided Drug Delivery in Solid Tumors

12. Rehabilitation versus surgical reconstruction for non-acute anterior cruciate ligament injury (ACL SNNAP): a pragmatic randomised controlled trial

24. Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

25. Structural Factors Contributing to Compassion Fatigue, Burnout, and Secondary Traumatic Stress Among Hospital-Based Healthcare Professionals During the COVID-19 Pandemic.

28. Online Professional Learning Networks: A Viable Solution to the Professional Development Dilemma

32. Community-Based Prevention Services for High-Risk Youth: A Study of the Governors' DFSCA Program. Final Report.

33. Spatial and temporal scales of the morphodynamic evolution within the Studland complex

34. Albumin-binding RNAi Conjugate for Carrier Free Treatment of Arthritis

35. Evaluation of emergency care education and triage implementation: an observational study at a hospital in rural Liberia

38. Data from Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

39. Supplementary Data Figure 5 from Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

40. Supplementary Data Tables from Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

41. Figure S3 from Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association Study

42. Supplementary Data Figure 6 from Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

43. Supplementary Data Figure 7 from Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

44. Supplementary Data Figure 2 from Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

45. Supplementary Figures S1 and S2 from Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL Blockade

46. Data from Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association Study

47. Supplementary Data Figure 4 from Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

49. Supplementary Data Figure Legends from Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

50. Supplementary Data Figure 3 from Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

Catalog

Books, media, physical & digital resources